<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(12)</volume><submitter>Forcade E</submitter><pubmed_abstract>Chronic graft-versus-host disease (cGvHD) remains a major complication of allogeneic stem cell transplantation requiring novel therapies. CD146 and CCR5 are expressed by activated T cells and associated with increased T cell migration capacity and Th17 polarization. We performed a multiparametric flow cytometry analysis in a cohort of 40 HSCT patients together with a cGvHD murine model to understand the role of CD146-expressing subsets. We observed an increased frequency of CD146+ CD4 T cells in the 20 patients with active cGvHD with enhanced RORγt expression. This Th17-prone subset was enriched for cells coexpressing CD146 and CCR5 that harbor mixed Th1/Th17 features and were more frequent in cGvHD patients. Utilizing a murine cGvHD model with bronchiolitis obliterans (BO), we observed th</pubmed_abstract><journal>JCI insight</journal><pagination>92111</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5470889</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.</pubmed_title><pmcid>PMC5470889</pmcid><pubmed_authors>MacDonald KP</pubmed_authors><pubmed_authors>Blanco P</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Blazar BR</pubmed_authors><pubmed_authors>Serody JS</pubmed_authors><pubmed_authors>Koreth J</pubmed_authors><pubmed_authors>Espada EL</pubmed_authors><pubmed_authors>Cutler CS</pubmed_authors><pubmed_authors>Flynn R</pubmed_authors><pubmed_authors>Soiffer RJ</pubmed_authors><pubmed_authors>Hill GR</pubmed_authors><pubmed_authors>Chu HW</pubmed_authors><pubmed_authors>Paz K</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Wilkes DS</pubmed_authors><pubmed_authors>Gartlan K</pubmed_authors><pubmed_authors>Ritz J</pubmed_authors><pubmed_authors>Bakoyannis G</pubmed_authors><pubmed_authors>Lobera M</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Antin JH</pubmed_authors><pubmed_authors>Amet T</pubmed_authors><pubmed_authors>Forcade E</pubmed_authors><pubmed_authors>Griesenauer B</pubmed_authors><pubmed_authors>Jiang D</pubmed_authors><pubmed_authors>Du J</pubmed_authors><pubmed_authors>Paczesny S</pubmed_authors></additional><is_claimable>false</is_claimable><name>An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.</name><description>Chronic graft-versus-host disease (cGvHD) remains a major complication of allogeneic stem cell transplantation requiring novel therapies. CD146 and CCR5 are expressed by activated T cells and associated with increased T cell migration capacity and Th17 polarization. We performed a multiparametric flow cytometry analysis in a cohort of 40 HSCT patients together with a cGvHD murine model to understand the role of CD146-expressing subsets. We observed an increased frequency of CD146+ CD4 T cells in the 20 patients with active cGvHD with enhanced RORγt expression. This Th17-prone subset was enriched for cells coexpressing CD146 and CCR5 that harbor mixed Th1/Th17 features and were more frequent in cGvHD patients. Utilizing a murine cGvHD model with bronchiolitis obliterans (BO), we observed th</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jun</publication><modification>2025-04-19T13:37:16.746Z</modification><creation>2019-03-27T02:47:38Z</creation></dates><accession>S-EPMC5470889</accession><cross_references><pubmed>28614794</pubmed><doi>10.1172/jci.insight.92111</doi></cross_references></HashMap>